A, M., GSS, G., CJD, R., & BC, C. (2024). The Role of Pharmacogenomics in Rare Diseases. Drug safety, 47(6), 521. https://doi.org/10.1007/s40264-024-01416-6
Chicago Style (17th ed.) CitationA, Man, Groeneweg GSS, Ross CJD, and Carleton BC. "The Role of Pharmacogenomics in Rare Diseases." Drug Safety 47, no. 6 (2024): 521. https://doi.org/10.1007/s40264-024-01416-6.
MLA (9th ed.) CitationA, Man, et al. "The Role of Pharmacogenomics in Rare Diseases." Drug Safety, vol. 47, no. 6, 2024, p. 521, https://doi.org/10.1007/s40264-024-01416-6.
Warning: These citations may not always be 100% accurate.